This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Editor's note: As part of the celebration of AuntMinnie.com's upcoming 25th anniversary, we're presenting 25 for 25 -- a series featuring our most popular content for each of the last 25 years. New articles will be published each Monday until our official anniversary at RSNA 2024. MRI safety articles have always been popular with our members, so it’s not surprising that our top article in 2019 reported on a safety incident in Sweden.
Qure.ai plans to collaborate with Roche Diagnostics Asia Pacific under that company's Startup Creasphere Asia-Pacific (APAC) Batch Four initiative. The partnership will make Qure.ai's medical imaging offerings available in the region -- particularly for cardiovascular and lung conditions -- through Roche's diagnostic portfolio. Roche established Startup Creasphere in 2018 in Munich, Germany, according to Qure.ai.
If it seems like recruiting at your company is getting more and more challenging, you’re not alone. A January 2024 survey found that 77% of HR professionals reported difficulty recruiting in the prior 12 months. Whether it’s navigating a talent shortage or landing great candidates with multiple job offers, most companies could use a recruiting advantage.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Breast biopsies are the most common image-guided procedure. Despite this, many radiology residents may not be routinely involved in completing these procedures during their training.
We covered the major points of the 2025 Medicare Physician Fee Schedule (MPFS) Proposed Rule when it came out in July, but while we’re waiting for the Final Rule to be published later in the year let’s look at another provision in the MPFS that we’ve been watching – the locality-specific payment adjustment known as the Geographic Practice Cost Index (GPCI).
We covered the major points of the 2025 Medicare Physician Fee Schedule (MPFS) Proposed Rule when it came out in July, but while we’re waiting for the Final Rule to be published later in the year let’s look at another provision in the MPFS that we’ve been watching – the locality-specific payment adjustment known as the Geographic Practice Cost Index (GPCI).
Seetharam Chadalavada, MD. PocketHealth Image exchange company PocketHealth has appointed Seetharam Chadalavada, MD, as its new chief medical officer (CMO). Chadalavada has more than 20 years of experience in radiology, informatics, and clinical practice. He currently practices at UC Health in Cincinnati. His expertise in minimally invasive, image-guided treatments for vascular, oncologic, and hepatobiliary conditions.
In a 10-year study involving over 5,400 women with nearly 85 percent having dense breasts, contrast-enhanced mammography (CEM) demonstrated a 95.9 percent sensitivity rate for breast cancer.
Fujifilm Healthcare Americas is launching Version 10 (v10) of its Echelon Synergy 1.5-tesla MRI system. Echelon Synergy v10 includes features such as Synergy DLR Clear, Synergy Vision with StillShot, and automated scanning process enhancements. Synergy Vision, now available for Echelon Synergy MRI, combines multiple in-bore cameras with StillShot AI to mitigate the impact of motion artifacts.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
AI developer HeartLung Technologies has received breakthrough medical device designation and marketing authorization from the U.S. Food and Drug Administration (FDA) for its Automated Cardiac Chambers Volumetry (AutoChamber) software. AutoChamber reports the volume of cardiac chambers and left ventricular wall mass in noncontrast CT scans for coronary artery calcium (CAC) scoring and in lung scans for lung cancer screening.
The American College of Radiology (ACR) has released an update to its ACR Appropriateness Criteria. The update consists of 247 diagnostic imaging and interventional radiology topics and covers 4,000 clinical scenarios, and now includes eight new and 18 revised topics.
A new study indicates that even with modest improvements in early detection, PSMA-PET imaging may enhance both the length and quality of life for patients dealing with recurrent prostate cancer.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Philips reported a slight decrease in revenues for its third quarter. For the period (end-September 30), the company posted revenues of 4.4 billion euros ($4.8 billion U.S.), slightly down from 4.5 billion euros ($4.9 billion) for the same period last year. Philips attributed the result to a decrease in demand from Chinese hospitals and consumers, although "China remains a fundamentally attractive growth market for Philips in the long term, with market conditions expected to remain uncertain," i
Kromek has reported a revenue increase for its full year. For the period (end-April 30), the company posted revenue of 23.4 million euros ($25.3 million U.S.), up 24% compared with 20.4 million euros ($22.1 million) last year. Net loss for the year was 4.2 million euros ($3.7 million) down from 2023's 7.7 million euros ($8.3 million). Kromek continues development of cadmium zinc telluride (CZT) detectors for photon counting CT and noted the launch of Spectrum Dynamics Medical's SPT/CT device Ver
Carbon-14 radiolabelling enables researchers to trace drug metabolism precisely, aiding in comprehensive ADME studies and safety assessments. The post The Role of Carbon-14 Radiolabelling in ADME Studies appeared first on Open MedScience.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
The U.S. Food and Drug Administration (FDA) has issued a warning to consumers, healthcare providers, and healthcare facilities not to use Hologic's BioZorb and BioZorb LP radiographic markers. On October 24 Hologic issued a voluntary recall for all lots of unused BioZorb markers, which are for radiographic marking in soft tissue, including breast tissue.
A partnership between Royal Philips and Medtronic Neurovascular, two leaders in stroke diagnosis and treatment, aims to enhance access to life-saving therapies.
Intraarterial peptide receptor radionuclide therapy (PRRT) is a safe and effective alternative to intravenous PRRT in patients with advanced meningioma, according to a study published October 24 in the Journal of Nuclear Medicine. Researchers at the University of Augsburg in Germany suggest the approach has the potential to deliver higher radiation doses to tumors, and found it safe in patients over a three-year follow-up period.
The Massachusetts Court of Appeals has ruled that a Massachusetts radiology services provider could be held liable for failing to provide a patient with access to an on-call interventional radiologist, according to a report published October 28 by Law.com. The decision states that Saint Vincent Radiological Associates (SVRA) in Worcester had a contractual agreement with Saint Vincent Hospital to provide an on-call interventional radiologist to the hospital.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
147 
Let's personalize your content